Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

CLL Society Ed Forum On Demand: ASH 2020 Comes to You!

In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical advice, and should never be acted on without review with your health care team.

Recorded Thursday, February 4, 2021

CLL Society brings ASH 2020 to you! Important research has been presented at the American Society of Hematology Annual Meeting and now, CLL Society brings you CLL experts to explain what top discoveries you need to know. 

Dr. Anthony Mato explains the excitement around LOXO-305, updates from the inform CLL Registry, which confirms CLL Society’s Test Before Treat™ campaign, the impact of del(17p) survival of CLL patients with ibrutinib frontline, and a one-pill triple combination targeting Richter Transformation. 

Dr. William Wierda explains the TRANSCEND Study: Liso-cel (JCAR017) in combination with ibrutinib, as well as present data from the MRD Cohort of the CAPTIVATE Study. 

You will also hear the caregiver perspective about why paying attention to research from ASH is critically important to the wellbeing of CLL patients and how CLL Society delivers this cutting-edge research to you. This forum and discussion will be slightly advanced, above the beginner level, but we invite everyone to join and learn. 

WELCOME
Patricia Koffman
CLL Society

INTRODUCTIONS
Brian Koffman, MDCM (retired)
CLL Society

SPEAKER
Anthony Mato, MD, MSCE
Director, CLL Program
Memorial Sloan Kettering Cancer Center

SPEAKER
William G. Wierda, MD, PhD
The University of Texas
MD Anderson Cancer Center

SPEAKER
Brian Koffman, MDCM (retired) MS Ed,
Chief Medical Officer, CLL Society

SPEAKER
Linda Lannom,
Patient Advocate, Co-Facilitator, CLL Society Oberlin, OH CLL Support Group

SPEAKER
Robyn Brumble, RN,
Director of Scientific Affairs, CLL Society

ALL PRESENTERS

  • Anthony Mato, MD, MSCE
  • William G. Wierda, MD, PhD
  • Brian Koffman, MDCM (retired) MS Ed

This program was made possible by grant support from AbbVie and Genentech.